NCT04128189View on ClinicalTrials.gov

Shingrix in Renal Transplant Recipients

PHASE3RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

September 30, 2026

Conditions
Kidney Transplant Recipient Response to Shingrix Vaccine
Interventions
BIOLOGICAL

Shingrix

Both arms receive standard 2 doses of Shingrix. Transplanted subjects may receive 3rd dose.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER